Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/EQUILLIUM-INC-46555746/nieuws/Equillium-kondigt-de-start-aan-van-Fase-1-studie-van-EQ102-een-multi-cytokine-remmer-van-IL-15-en-I-42189661/?utm_source=whatsapp&utm_medium=social&utm_campaign=share